The lawsuits began piling in October 2021 — about four months after the recall — according to court documents. Since then, the FDA has reported more than 105,000 injuries and 385 deaths related to the recall.
Philips Respironics filed for a partial settlement agreement, which is subject to the court’s approval, to offer between $50 and $1,500 to each customer, according to The New York Times.
In a news release, the company said the decision is not an admission of liability or guilt.
